Orakl Oncology

📍 Paris, France👥 29 employees💰 Last funded Nov 2024
Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster.
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography2 countries
France
2
United Kingdom
1
Investor activity2023–2024 · investors recorded per year
2023220241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Orakl Oncology?
Orakl Oncology has 3 investors on record on gritt.io.
When did Orakl Oncology last raise funding?
The most recent investment in Orakl Oncology recorded on gritt.io was in November 2024.
What industry is Orakl Oncology in?
Orakl Oncology operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Orakl Oncology based?
Orakl Oncology is headquartered in Paris, France.